Biomea Fusion, Inc. Total Liabilities
Biomea Fusion, Inc. (BMEA) had Total Liabilities of $24.74 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-05
- 2026-06-30: Liabilities $24.74M.
- 2026-03-31: Liabilities $27.67M.
- 2025-12-31: Liabilities $29.02M.
- 2025-09-30: Liabilities $39.57M.
| Period end | Liabilities |
|---|---|
| 2026-06-30 | $24.74M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $27.67M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $29.02M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $39.57M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $45.65M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $26.32M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $28.36M 10-K · filed 2026-03-24 |
| 2024-09-30 | $34.45M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $32.22M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $33.18M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $30.69M 10-K · filed 2025-03-31 |
| 2023-09-30 | $25.48M 10-Q · filed 2023-10-30 |
| 2023-06-30 | $24.37M 10-Q · filed 2023-07-31 |
| 2023-03-31 | $29.51M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $20.77M 10-K · filed 2024-03-28 |
| 2022-09-30 | $14.41M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $11.35M 10-Q · filed 2022-08-01 |
| 2022-03-31 | $10.10M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $6.92M 10-K · filed 2023-03-28 |
| 2021-09-30 | $8.07M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $7.52M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $3.92M 10-Q · filed 2021-05-27 |
| 2020-12-31 | $1.62M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |